These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 25941161

  • 1. Metabolic abnormalities of the heart in type II diabetes.
    Amaral N, Okonko DO.
    Diab Vasc Dis Res; 2015 Jul; 12(4):239-48. PubMed ID: 25941161
    [Abstract] [Full Text] [Related]

  • 2. Chronic heart failure and type 2 diabetes mellitus: The last battle?
    Kearney MT.
    Diab Vasc Dis Res; 2015 Jul; 12(4):226-7. PubMed ID: 26099813
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Altered mitochondrial metabolism in the insulin-resistant heart.
    Makrecka-Kuka M, Liepinsh E, Murray AJ, Lemieux H, Dambrova M, Tepp K, Puurand M, Käämbre T, Han WH, de Goede P, O'Brien KA, Turan B, Tuncay E, Olgar Y, Rolo AP, Palmeira CM, Boardman NT, Wüst RCI, Larsen TS.
    Acta Physiol (Oxf); 2020 Mar; 228(3):e13430. PubMed ID: 31840389
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications.
    Kota SK, Kota SK, Jammula S, Panda S, Modi KD.
    Diabetes Technol Ther; 2011 Nov; 13(11):1155-60. PubMed ID: 21751873
    [Abstract] [Full Text] [Related]

  • 8. Metabolic support for the heart: complementary therapy for heart failure?
    Heggermont WA, Papageorgiou AP, Heymans S, van Bilsen M.
    Eur J Heart Fail; 2016 Dec; 18(12):1420-1429. PubMed ID: 27813339
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy.
    Carpentier AC.
    Can J Cardiol; 2018 May; 34(5):605-614. PubMed ID: 29627307
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart.
    Pham T, Loiselle D, Power A, Hickey AJ.
    Am J Physiol Cell Physiol; 2014 Sep 15; 307(6):C499-507. PubMed ID: 24920675
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.
    Fillmore N, Mori J, Lopaschuk GD.
    Br J Pharmacol; 2014 Apr 15; 171(8):2080-90. PubMed ID: 24147975
    [Abstract] [Full Text] [Related]

  • 19. Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure.
    Dalal JJ, Mishra S.
    Indian Heart J; 2017 Apr 15; 69(3):393-401. PubMed ID: 28648439
    [Abstract] [Full Text] [Related]

  • 20. Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation.
    Gopal K, Karwi QG, Tabatabaei Dakhili SA, Wagg CS, Zhang L, Sun Q, Saed CT, Panidarapu S, Perfetti R, Ramasamy R, Ussher JR, Lopaschuk GD.
    Cardiovasc Diabetol; 2023 Mar 28; 22(1):73. PubMed ID: 36978133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.